Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 15

    1.

    Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke.

    Deutsch C, Portik-Dobos V, Smith AD, Ergul A, Dorrance AM.

    Microvasc Res. 2009 Jun;78(1):100-6. Epub 2009 Apr 15.PMID: 19374911 [PubMed - indexed for MEDLINE]Related articles

    2.

    Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1.

    Elgebaly MM, Kelly A, Harris AK, Elewa H, Portik-Dobos V, Ketsawatsomkron P, Marrero M, Ergul A.

    Can J Physiol Pharmacol. 2008 Jun;86(6):358-64.PMID: 18516099 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

    Sachidanandam K, Elgebaly MM, Harris AK, Hutchinson JR, Mezzetti EM, Portik-Dobos V, Ergul A.

    Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2743-9. Epub 2008 Apr 18.PMID: 18424628 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes.

    Sachidanandam K, Portik-Dobos V, Harris AK, Hutchinson JR, Muller E, Johnson MH, Ergul A.

    Diabetes. 2007 Nov;56(11):2753-8. Epub 2007 Aug 1.PMID: 17670915 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes.

    Elgebaly MM, Portik-Dobos V, Sachidanandam K, Rychly D, Malcom D, Johnson MH, Ergul A.

    Vascul Pharmacol. 2007 Aug-Sep;47(2-3):125-30. Epub 2007 Jun 6.PMID: 17597010 [PubMed - indexed for MEDLINE]Related articles

    6.

    Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes.

    Portik-Dobos V, Harris AK, Song W, Hutchinson J, Johnson MH, Imig JD, Pollock DM, Ergul A.

    Am J Physiol Regul Integr Comp Physiol. 2006 Feb;290(2):R435-41. Epub 2005 Oct 20.PMID: 16239374 [PubMed - indexed for MEDLINE]Related articles

    7.

    Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.

    Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP.

    Am J Hypertens. 2004 Sep;17(9):775-82.PMID: 15363819 [PubMed - indexed for MEDLINE]Related articles

    8.

    Native matrix metalloproteinase characteristics may influence early stenosis of venous versus arterial coronary artery bypass grafting conduits.

    Anstadt MP, Franga DL, Portik-Dobos V, Pennathur A, Bannan M, Mawulawde K, Ergul A.

    Chest. 2004 May;125(5):1853-8.PMID: 15136400 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation.

    Ergul A, Portik-Dobos V, Giulumian AD, Molero MM, Fuchs LC.

    Am J Physiol Heart Circ Physiol. 2003 Nov;285(5):H2225-32. Epub 2003 Jul 3.PMID: 12842810 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Decreased vascular matrix metalloproteinase abundance in diabetic patients with symptomatic macroangiopathy.

    Mondy JS, Anstadt MP, Franga DL, Portik-Dobos V, Hutchinson J, Ergul A.

    Ethn Dis. 2002 Fall;12(4):S3-18-22.PMID: 12477149 [PubMed - indexed for MEDLINE]Related articles

    11.

    Vascular endothelin converting enzyme-1 expression and activity is upregulated in clinical diabetes.

    Anstadt MP, Hutchinson J, Portik-Dobos V, Jafri F, Bannan M, Mawulawde K, Ergul A.

    Ethn Dis. 2002 Fall;12(4):S3-5-9.PMID: 12477147 [PubMed - indexed for MEDLINE]Related articles

    12.

    Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes.

    Portik-Dobos V, Anstadt MP, Hutchinson J, Bannan M, Ergul A.

    Diabetes. 2002 Oct;51(10):3063-8.PMID: 12351448 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Arterial pressure response to endothelin-1 and sarafotoxin 6c in rescued endothelin-B-deficient rats.

    Pollock DM, Portik-Dobos V, Procter C, Gariepy CE, Yanagisawa M.

    J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S82-5.PMID: 11078343 [PubMed - indexed for MEDLINE]Related articles

    14.

    Induction of HLA-G-specific human CD8+ T cell lines by stimulation across a polymorphism of HLA-G.

    Horuzsko A, Portik-Dobos V, Hansen KA, Markowitz RB, Helman SW, Mellor AL.

    Transplant Proc. 1999 Jun;31(4):1860-3. No abstract available. PMID: 10371974 [PubMed - indexed for MEDLINE]Related articles

    15.

    HLA-G functions as a restriction element and a transplantation antigen in mice.

    Horuzsko A, Antoniou J, Tomlinson P, Portik-Dobos V, Mellor AL.

    Int Immunol. 1997 May;9(5):645-53.PMID: 9184910 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...